Macrogenics reported $83.99M in Cash and Equivalent for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Amgen AMGN:US USD 9.3B 197M
AstraZeneca AZN:LN USD 4.46B 359M
Biogen BIIB:US USD 3.68B 1.03B
Bristol Myers Squibb BMY:US USD 7.73B 3.02B
Daiichi Sankyo 4568:JP JPY 395.18B 85.04B
Eli Lilly And LLY:US USD 2.62B 5.5M
Genmab GEN:DC DKK 10.38B 561M
Geron GERN:US USD 61.47M 14.59M
Gilead Sciences GILD:US USD 4.7B 40M
Immunogen IMGN:US USD 309.51M 64.36M
Karyopharm Therapeutics KPTI:US USD 71.35M 10.9M
Macrogenics MGNX:US USD 83.99M 62.52M
Merk MRK:US USD 11.15B 1.47B
Mirati Therapeutics MRTX:US USD 173.53M 71.97M
Puma Biotechnology PBYI:US USD 77.96M 25.2M
Regeneron Pharmaceuticals REGN:US USD 3.49B 96.2M
Roche Holding ROG:VX 4.32B 2.54B
Seattle Genetics SGEN:US USD 362.6M 2.27M
Xencor XNCR:US USD 52.65M 3.24M